These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9615235)

  • 1. Localization of human cadherin genes to chromosome regions exhibiting cancer-related loss of heterozygosity.
    Kremmidiotis G; Baker E; Crawford J; Eyre HJ; Nahmias J; Callen DF
    Genomics; 1998 May; 49(3):467-71. PubMed ID: 9615235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allele loss on chromosome 16q24.2-qter occurs frequently in breast cancers irrespectively of differences in phenotype and extent of spread.
    Tsuda H; Callen DF; Fukutomi T; Nakamura Y; Hirohashi S
    Cancer Res; 1994 Jan; 54(2):513-7. PubMed ID: 8275489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping of a cadherin gene cluster to a region of chromosome 5 subject to frequent allelic loss in carcinoma.
    Chalmers IJ; Höfler H; Atkinson MJ
    Genomics; 1999 Apr; 57(1):160-3. PubMed ID: 10191097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas.
    Toyooka KO; Toyooka S; Virmani AK; Sathyanarayana UG; Euhus DM; Gilcrease M; Minna JD; Gazdar AF
    Cancer Res; 2001 Jun; 61(11):4556-60. PubMed ID: 11389090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allelic loss in a minimal region on chromosome 16q24 is associated with vitreous seeding of retinoblastoma.
    Gratias S; Rieder H; Ullmann R; Klein-Hitpass L; Schneider S; Bölöni R; Kappler M; Lohmann DR
    Cancer Res; 2007 Jan; 67(1):408-16. PubMed ID: 17210724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CBFA2T3 (MTG16) is a putative breast tumor suppressor gene from the breast cancer loss of heterozygosity region at 16q24.3.
    Kochetkova M; McKenzie OL; Bais AJ; Martin JM; Secker GA; Seshadri R; Powell JA; Hinze SJ; Gardner AE; Spendlove HE; O'Callaghan NJ; Cleton-Jansen AM; Cornelisse C; Whitmore SA; Crawford J; Kremmidiotis G; Sutherland GR; Callen DF
    Cancer Res; 2002 Aug; 62(16):4599-604. PubMed ID: 12183414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction of a high-resolution physical and transcription map of chromosome 16q24.3: a region of frequent loss of heterozygosity in sporadic breast cancer.
    Whitmore SA; Crawford J; Apostolou S; Eyre H; Baker E; Lower KM; Settasatian C; Goldup S; Seshadri R; Gibson RA; Mathew CG; Cleton-Jansen AM; Savoia A; Pronk JC; Auerbach AD; Doggett NA; Sutherland GR; Callen DF
    Genomics; 1998 May; 50(1):1-8. PubMed ID: 9628816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping of regions of physical deletion on chromosome 16q in prostate cancer cells by fluorescence in situ hybridization (FISH).
    Cher ML; Ito T; Weidner N; Carroll PR; Jensen RH
    J Urol; 1995 Jan; 153(1):249-54. PubMed ID: 7966782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosome band 16q24 is frequently deleted in human gastric cancer.
    Mori Y; Matsunaga M; Abe T; Fukushige S; Miura K; Sunamura M; Shiiba K; Sato M; Nukiwa T; Horii A
    Br J Cancer; 1999 May; 80(3-4):556-62. PubMed ID: 10408866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity mapping at chromosome arm 16q in 712 breast tumors reveals factors that influence delineation of candidate regions.
    Cleton-Jansen AM; Callen DF; Seshadri R; Goldup S; Mccallum B; Crawford J; Powell JA; Settasatian C; van Beerendonk H; Moerland EW; Smit VT; Harris WH; Millis R; Morgan NV; Barnes D; Mathew CG; Cornelisse CJ
    Cancer Res; 2001 Feb; 61(3):1171-7. PubMed ID: 11221848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-resolution integrated map encompassing the breast cancer loss of heterozygosity region on human chromosome 16q22.1.
    Frengen E; Rocca-Serra P; Shaposhnikov S; Taine L; Thorsen J; Bepoldin C; Krekling M; Lafon D; Aas KK; El Monéim AA; Johansen H; Longy M; Prydz H; Dorion-Bonnet F
    Genomics; 2000 Dec; 70(3):273-85. PubMed ID: 11161777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of the chromosomal region 5q11-q31 in the myeloid cell line HL-60: characterization by comparative genomic hybridization and fluorescence in situ hybridization.
    Shipley J; Weber-Hall S; Birdsall S
    Genes Chromosomes Cancer; 1996 Mar; 15(3):182-6. PubMed ID: 8721684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosome 16 tumor-suppressor genes in breast cancer.
    Rakha EA; Green AR; Powe DG; Roylance R; Ellis IO
    Genes Chromosomes Cancer; 2006 Jun; 45(6):527-35. PubMed ID: 16518845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of three novel human cadherin genes (CDH7, CDH19, and CDH20) clustered on chromosome 18q22-q23 and with high homology to chicken cadherin-7.
    Kools P; Van Imschoot G; van Roy F
    Genomics; 2000 Sep; 68(3):283-95. PubMed ID: 10995570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features.
    Wei Y; Van Nhieu JT; Prigent S; Srivatanakul P; Tiollais P; Buendia MA
    Hepatology; 2002 Sep; 36(3):692-701. PubMed ID: 12198663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic aberration in primary hepatocellular carcinoma: correlation between p53 gene mutation and loss-of-heterozygosity on chromosome 16q21-q23 and 9p21-p23.
    Wang G; Huang CH; Zhao Y; Cai L; Wang Y; Xiu SJ; Jiang ZW; Yang S; Zhao T; Huang W; Gu JR
    Cell Res; 2000 Dec; 10(4):311-23. PubMed ID: 11191353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refined mapping of the region of loss of heterozygosity on the long arm of chromosome 7 in human breast cancer defines the location of a second tumor suppressor gene at 7q22 in the region of the CUTL1 gene.
    Zeng WR; Watson P; Lin J; Jothy S; Lidereau R; Park M; Nepveu A
    Oncogene; 1999 Mar; 18(11):2015-21. PubMed ID: 10208423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of a tumor suppressor gene associated with the progression of human breast carcinoma within a 1-cM interval of 8p22-p23.1.
    Yokota T; Yoshimoto M; Akiyama F; Sakamoto G; Kasumi F; Nakamura Y; Emi M
    Cancer; 1999 Jan; 85(2):447-52. PubMed ID: 10023714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal 16q genomic loss implicates cadherin-11 in retinoblastoma.
    Marchong MN; Chen D; Corson TW; Lee C; Harmandayan M; Bowles E; Chen N; Gallie BL
    Mol Cancer Res; 2004 Sep; 2(9):495-503. PubMed ID: 15383628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation in liver tissues and cell lines of the transcription of 13 genes mapping to the 16q24 region that are frequently deleted in hepatocellular carcinoma.
    Riou P; Saffroy R; Comoy J; Gross-Goupil M; Thiéry JP; Emile JF; Azoulay D; Piatier-Tonneau D; Lemoine A; Debuire B
    Clin Cancer Res; 2002 Oct; 8(10):3178-86. PubMed ID: 12374686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.